Center for Platelet Function Studies



Mark I. Furman, MD

Current Research Funding

The Effect of LDL Apheresis on Platelet and Leukocyte Activation, Leukocyte-Platelet Aggregation, Kaneka American/Parke Davis Pharmaceuticals, Principal Investigator (Collaboration with Andrew P. Selwyn, M.D., Brigham and Women's Hospital), $23,750 Direct Costs

Detection of Platelet Surface CD40L and Soluble CD40L: Effects of GPIIb-IIIa Antagonists. Principal Investigator, Centocor, Inc. $78,166 Direct Costs

Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE 2). Principal Investigator. The Medicines Company. $64,000 Direct Costs

Correlation Of In Vitro And In Vivo Determination Of Aspirin Resistance. Principal Investigator, Dade Behring, $225,797 Direct Costs

Effects of the Medtronic Distal Protection Device on Platelet Activation (Phase 1 & 2) Principal Investigator, Medtronic AVE, $62, 000 Direct Costs